Abstract
CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have